sulpiride has been researched along with Polycystic Ovary Syndrome in 4 studies
Sulpiride: A dopamine D2-receptor antagonist. It has been used therapeutically as an antidepressant, antipsychotic, and as a digestive aid. (From Merck Index, 11th ed)
sulpiride : A member of the class of benzamides obtained from formal condensation between the carboxy group of 2-methoxy-5-sulfamoylbenzoic acid and the primary amino group of (1-ethylpyrrolidin-2-yl)methylamine.
Polycystic Ovary Syndrome: A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In order to evaluate the functional activity of the tubero-infundibular dopaminergic system in polycystic ovary syndrome (PCOS), we analysed the prolactin (PRL) and thyrotropin (TSH) responses to the dopamine antagonist sulpiride." | 3.68 | Evidence of altered dopaminergic modulation of prolactin and thyrotropin secretion in patients with polycystic ovary syndrome. ( Marrama, P; Pantaleoni, M; Velardo, A; Zironi, C; Zizzo, G, 1991) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peritogiannis, V | 1 |
| Goulia, P | 1 |
| Pappas, D | 1 |
| Hyphantis, T | 1 |
| Mavreas, V | 1 |
| Paoletti, AM | 1 |
| Cagnacci, A | 1 |
| Soldani, R | 1 |
| Orrù, M | 1 |
| Ajossa, S | 1 |
| Pittorra, G | 1 |
| Mulas, P | 1 |
| Melis, GB | 1 |
| Zironi, C | 2 |
| Pantaleoni, M | 2 |
| Zizzo, G | 2 |
| Coletta, F | 1 |
| Velardo, A | 2 |
| Marrama, P | 1 |
1 trial available for sulpiride and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
[Evaluation of dopaminergic activity of the hypothalamus in patients with polycystic ovarian syndrome].
Topics: Dopamine Agents; Drug Evaluation; Female; Follicle Stimulating Hormone; Humans; Hypothalamus; Lutein | 1991 |
3 other studies available for sulpiride and Polycystic Ovary Syndrome
| Article | Year |
|---|---|
Amenorrhea after sertraline introduction in an amisulpride-treated patient with undiagnosed polycystic ovary disease.
Topics: Adult; Amenorrhea; Amisulpride; Antipsychotic Agents; Depression; Drug Interactions; Female; Humans; | 2007 |
Evidence that an altered prolactin release is consequent to abnormal ovarian activity in polycystic ovary syndrome.
Topics: Delayed-Action Preparations; Dopamine; Dopamine Antagonists; Estradiol; Female; Goserelin; Humans; M | 1995 |
Evidence of altered dopaminergic modulation of prolactin and thyrotropin secretion in patients with polycystic ovary syndrome.
Topics: Adolescent; Adult; Dopamine; Dopamine Antagonists; Female; Follicle Stimulating Hormone; Humans; Kin | 1991 |